EFFECTS OF LORAZEPAM AND ITS WITHDRAWAL ON SLEEP, PERFORMANCE, AND SUBJECTIVE STATE

被引：22

作者：

WALSH, JK

SCHWEITZER, PK

PARWATIKAR, S

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 34卷 / 04期

关键词：

D O I：

10.1038/clpt.1983.203

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：496 / 500

页数：5

共 11 条

[1] ANXIETY AND SLEEP AFTER FOSAZEPAM [J].

ALLEN, S ;

OSWALD, I .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (01) :165-168

[2]

DEMENT WC, 1982, SLEEP, V5, pS25

[3] MULTIPLE COMPARISONS AMONG MEANS [J].

DUNN, OJ .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1961, 56 (293) :52-&

[4] CLINICAL PHARMACOKINETICS OF OXAZEPAM AND LORAZEPAM [J].

GREENBLATT, DJ .

CLINICAL PHARMACOKINETICS, 1981, 6 (02) :89-105

[5] REBOUND INSOMNIA - NEW CLINICAL SYNDROME [J].

KALES, A ;

SCHARF, MB ;

KALES, JD .

SCIENCE, 1978, 201 (4360) :1039-1041

[6] HYPNOTICS - REBOUND INSOMNIA AND RESIDUAL SEQUELAE [J].

NICHOLSON, AN .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (03) :223-225

[7]

NICHOLSON AN, 1981, BRIT J CLIN PHARMACO, V11, pS61

[8]

RECHTSCHAFFEN A, 1968, PHS PUBLICATIONS, V204

[9]

ROTH T, 1981, BRIT J CLIN PHARMACO, V11, pS31

[10] LORAZEPAM - EFFICACY, SIDE-EFFECTS, AND REBOUND PHENOMENA [J].

SCHARF, MB ;

JACOBY, JA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :175-179

← 1 2 →